Press "esc" to clear
Go to Advanced Search
Showing results 2130 of 5978
Embargo will expire:
18-Oct-2018 9:00 AM EDT
Released to reporters:
15-Oct-2018 9:45 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Oct-2018 9:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

VogeleLife.jpg

Article ID: 702143

The Easy Way May Not Be the Best

New York University

The steps cells take in response to challenges are more complex than previously thought, finds new research. The study investigates a system relevant to cancer, viral infection, and diabetes.

Released:
15-Oct-2018 8:00 AM EDT
SpringTree.jpg
  • Embargo expired:
    15-Oct-2018 12:15 AM EDT

Article ID: 702013

More Clues Revealed in Link Between Normal Breast Changes and Invasive Breast Cancer

Georgetown University Medical Center

A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process — changes in mammary glands to accommodate breastfeeding — uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Released:
11-Oct-2018 5:00 AM EDT

Article ID: 702156

NUS researchers elucidate roles of transcription factors, TP63 and SOX2, in squamous cell cancer progression

National University of Singapore

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore have identified a SCC-specific protein complex activated by TP63 and SOX2 which triggers a gene cascade that promotes SCC growth.

Released:
14-Oct-2018 9:05 PM EDT

Article ID: 702149

Mayo Clinic的研究人员确定了导致骨髓瘤种族差异的基因类型

Mayo Clinic

Mayo Clinic的研究人员已经确定了三种特定的基因类型,这些基因类型会使非洲裔美国人的骨髓瘤(myeloma)诊断增加两到三倍。 研究人员还展示了DNA分析在更准确地研究种族和种族混合上的效果。 该研究结果发表在《血癌学杂志》(Blood Cancer Journal)上。

Released:
12-Oct-2018 5:05 PM EDT
cell-quality-control-012.jpg

Article ID: 702145

Microfluidic Molecular Exchanger Helps Control Therapeutic Cell Manufacturing

Georgia Institute of Technology

Researchers have demonstrated an integrated technique for monitoring specific biomolecules – such as growth factors – that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics.

Released:
12-Oct-2018 4:05 PM EDT

Article ID: 702083

HSS Researchers Launch Clinical Trial to Determine if Popular Stem Cell Therapy Can Protect Damaged Knees from Osteoarthritis

Hospital for Special Surgery

Led by Andreas H. Gomoll, MD, sports medicine surgeon at Hospital for Special Surgery (HSS), the study is looking at the effects on knee function of ReNu, an allograft product composed of human amniotic membrane and cells from the amniotic fluid.

Released:
12-Oct-2018 2:05 PM EDT

Article ID: 702115

Is the Next Big Step in Cancer Therapy Personalized Vaccines?

University of California San Diego Health

Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.

Released:
12-Oct-2018 10:05 AM EDT
Mayumi.Fujita.2.jpg

Article ID: 702110

Cancer Stem Cells Use “Normal” Genes in Abnormal Ways

University of Colorado Cancer Center

University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."

Released:
12-Oct-2018 8:05 AM EDT
Paquette_GettyImages-559007831LR.jpg

Article ID: 702025

Cedars-Sinai Expert Joins Team Researching Rare Blood Cancer

Cedars-Sinai

Ronald Paquette, MD, clinical director of the Cedars-Sinai Blood & Marrow Transplant Program at the Samuel Oschin Comprehensive Cancer Institute, recently was accepted as a member of the Myeloproliferative Neoplasm Research Consortium. The group is funded by the National Cancer Institute.

Released:
12-Oct-2018 6:00 AM EDT

Showing results 2130 of 5978

Chat now!